Standard Chemical & Pharmaceutical Co. Ltd.

TWSE:1720 Stock Report

Market Cap: NT$13.1b

Standard Chemical & Pharmaceutical Dividend

Dividend criteria checks 4/6

Standard Chemical & Pharmaceutical is a dividend paying company with a current yield of 3.66% that is well covered by earnings. Next payment date is on 30th August, 2024 with an ex-dividend date of 1st August, 2024.

Key information

3.7%

Dividend yield

55%

Payout ratio

Industry average yield1.9%
Next dividend pay date30 Aug 24
Ex dividend date01 Aug 24
Dividend per sharen/a
Earnings per shareNT$4.91
Dividend yield forecast in 3Yn/a

Recent dividend updates

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Recent updates

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13
If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Mar 14
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Mar 01
Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Feb 16
Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Feb 03
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19
Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04
Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22
Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26
Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Upcoming Dividend Payment

TodayJul 16 2024Ex Dividend DateAug 01 2024Dividend Pay DateAug 30 202429 days from Ex DividendBuy in the next 15 days to receive the upcoming dividend

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 1720's dividend payments have been volatile in the past 10 years.

Growing Dividend: 1720's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Standard Chemical & Pharmaceutical Dividend Yield vs Market
How does 1720 dividend yield compare to the market?
SegmentDividend Yield
Company (1720)3.7%
Market Bottom 25% (TW)1.6%
Market Top 25% (TW)4.2%
Industry Average (Pharmaceuticals)1.9%
Analyst forecast in 3 Years (1720)n/a

Notable Dividend: 1720's dividend (3.66%) is higher than the bottom 25% of dividend payers in the TW market (1.63%).

High Dividend: 1720's dividend (3.66%) is low compared to the top 25% of dividend payers in the TW market (4.21%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (55%), 1720's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (67.2%), 1720's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.